OCTREOTIDE ACETATE 200 ug/mL

Octreotide Acetate 200 ug/mL is a somatostatin analog used for various therapeutic purposes. This injection solution is designed for intravenous administration and is manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Octreotide Acetate is primarily used to manage symptoms associated with certain gastrointestinal and pancreatic conditions. It is often prescribed for the treatment of acromegaly, a condition characterized by excessive growth hormone. Additionally, it may be used to control symptoms of carcinoid syndrome, a condition that can cause severe diarrhea and flushing. Octreotide Acetate is also utilized in the management of variceal bleeding and other conditions where somatostatin analogs are indicated.

Common effects of Octreotide Acetate may include nausea, vomiting, and abdominal pain. Some individuals may experience headaches, dizziness, or fatigue. Injection site reactions such as redness or swelling are also possible. These effects are generally mild and transient, but any persistent or severe symptoms should be discussed with a healthcare provider.

Octreotide Acetate should be handled with care, ensuring proper sterile techniques during administration. It is important to store the solution as directed to maintain its efficacy. Patients with a history of hypersensitivity to octreotide or any of its components should avoid its use. Always follow the guidance of a healthcare professional regarding the use of this medication.

Octreotide Acetate may interact with various medications, including those metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided as it may exacerbate certain side effects. Always consult with a healthcare professional before starting or stopping any medication.